Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1115418 BOSTON, MA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,106,144
+$471,723 QoQ
Shares Held
77,137
+13.3% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 158 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ZVRA ranks #129 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in ZVRA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,106,144 77,137
2026-03-31 $634,421 68,071
2025-12-31 $611,824 68,284
2025-09-30 $736,920 77,489
2025-06-30 $733,177 83,221
2025-03-31 $558,641 74,585
2024-12-31 $567,562 68,053
2024-09-30 $398,911 57,480
2024-06-30 $278,682 56,874
2024-03-31 $279,879 48,255
2023-12-31 $309,094 47,190
2023-09-30 $220,375 45,721
2023-06-30 $220,131 43,163
2022-03-31 $162,876 32,381
2021-12-31 $289,442 33,231
2021-09-30 $305,324 32,725
2021-06-30 $408,086 31,832